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Abstract
Background  and  objectives:  The  induction  and  inhibition  of  cytochrome  P450  isoenzymes  by
antiepileptic drugs  lead  to  changes  in  the  clearance  of  anesthetic  drugs  eliminated  via  hepatic
metabolism.  We  investigated  the  duration  of  the  sedation  and  additional  anesthetic  needs  dur-
ing  magnetic  resonance  imaging  in  epileptic  children  receiving  antiepileptic  drugs  that  cause
either  enzyme  induction  or  inhibition.
Methods:  In  American  Society  of  Anesthesiology  I--II,  120  children  aged  3--10  years  were
included. Group  1:  children  using  antiepileptic  drugs  that  cause  cytochrome  P450  enzyme
induction; Group  2:  those  using  antiepileptic  drugs  that  cause  inhibition;  and  Group  3:  those
that  did  not  use  antiepileptic  drugs.  Sedation  was  induced  with  the  use  of  0.05  mg  kg−1 mida-
zolam  and  1  mg  kg−1 propofol.  An  additional  0.05  mg  kg−1 of  midazolam  and  rescue  propofol
(0.5 mg  kg−1)  were  administered  and  repeated  to  maintain  sedation.  The  duration  of  sedation
and  the  additional  sedation  needed  were  compared.
Results:  The  duration  of  the  initial  dose  was  signiﬁcantly  shorter  in  Group  I  compared  with
groups II  and  III  (p  =  0.001,  p  =  0.003,  respectively).  It  was  signiﬁcantly  longer  in  Group  II  com-
pared  with  groups  I and  III  (p  =  0.001,  p  =  0.029,  respectively).  The  additional  midazolam  needed
for  adequate  sedation  was  increased  in  Group  I when  compared  with  groups  II  and  III  (p  =  0.010,
p  =  0.001,  respectively).  In  addition,  the  rescue  propofol  dose  was  signiﬁcantly  higher  only  in
Group  I  when  compared  with  Group  III  (p  =  0.002).
Conclusion:  In  epileptic  children,  the  response  variability  to  the  initial  sedative  agents  during
the magnetic  resonance  imaging  procedure  resulting  from  the  inhibition  or  induction  of  the
cytochrome  P450  isoenzymes  by  the  antiepileptic  drugs  mandated  the  titration  of  anesthetic
agents.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Impacto  de  diferentes  medicamentos  antiepilépticos  na  sedac¸ão  de  crianc¸as  durante
a  ressonância  magnética
Resumo
Justiﬁcativa  e  objetivos:  A  induc¸ão  e  a  inibic¸ão  das  isoenzimas  do  citocromo  P450  pelos
medicamentos  antiepilépticos  levam  a  alterac¸ões  na  depurac¸ão  de  medicamentos  anestésicos
eliminados  pelo  metabolismo  hepático.  Investigamos  a  durac¸ão  da  sedac¸ão  e  a  necessidade  adi-
cional  de  anestésicos  durante  a  ressonância  magnética  em  crianc¸as  epilépticas  que  receberam
antiepilépticos  que  causam  a  induc¸ão  ou  a  inibic¸ão  de  enzimas.
Métodos:  Foram  incluídas  no  estudo  120  crianc¸as,  estado  físico  ASA  I-II,  entre  3-10  anos.  Grupo
1: em  uso  de  antiepilépticos  que  causam  a  induc¸ão  de  enzimas  do  citocromo  P450;  Grupo  2:
em  uso  de  antiepilépticos  que  causam  a  inibic¸ão  de  enzimas  do  citocromo  P450;  e  Grupo  3:  que
não  usavam  antiepilépticos.  A  sedac¸ão  foi  induzida  com  midazolam  (0,05  mg  kg−1)  e  propofol
(1  mg  kg−1).  Um  adicional  de  0,05  mg  kg−1 de  midazolam  e  resgate  com  0,5  mg  kg−1 de  propofol
foram administrados  e  repetidos  para  manter  a  sedac¸ão.  A  durac¸ão  da  sedac¸ão  e  a  sedac¸ão
adicional necessária  foram  comparadas.
Resultados:  A  durac¸ão  da  dose  inicial  foi  signiﬁcativamente  menor  no  Grupo  I em  comparac¸ão
com os  grupos  II  e  III  (p  =  0,001,  p  =  0,003,  respectivamente)  e  signiﬁcativamente  maior  no  Grupo
II  em  comparac¸ão  com  os  grupos  I  e  III  (p  =  0,001,  p  =  0,029,  respectivamente).  A  necessidade
de midazolam  adicional  para  sedac¸ão  adequada  foi  maior  no  Grupo  I  em  comparac¸ão  com  os
grupos  II  e  III  (p  =  0,010,  p  =  0,001,  respectivamente).  Além  disso,  a  dose  de  resgate  de  propofol
foi  signiﬁcativamente  maior  apenas  no  Grupo  I  em  comparac¸ão  com  o  Grupo  III  (p  =  0,002).
Conclusão:  Em  crianc¸as  epilépticas,  a  variabilidade  da  resposta  aos  agentes  sedativos  iniciais
durante a  ressonância  magnética,  resultante  da  inibic¸ão  ou  induc¸ão  das  isoenzimas  do  citocromo
P450  pelos  medicamentos  antiepiléticos,  exigiu  a  titulac¸ão  dos  agentes  anestésicos.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  
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Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
Epilepsy  is  the  most  common  chronic  neurological  disorder
among children  and  is  characterized  by  paroxysmal  attacks.1
Magnetic  resonance  imaging  (MRI)  is  a  generally  preferred
imaging modality  in  the  management  of  epileptic  children.2
In  MRI  procedures,  the  selection  of  anesthetic  agents  with
anticonvulsant activity  as  well  as  drug  interactions  between
antiepileptic drugs  (AEDs)  and  anesthetics  are  integral  com-
ponents  of  the  anesthetic  plan  for  patients  with  epilepsy.3,4
The  induction  and  inhibition  of  cytochrome  P450  (CYP-
450) in  liver  metabolism  comprise  the  most  important
mechanism in  pharmacokinetic  drug  interactions  regarding
AEDs.4 Commonly  used  AEDs,  such  as  phenytoin,  carba-
mazepine, primidone  and  phenobarbital  induce  several  CPY
isoenzymes  (CYP1A2,  CYP2C9,  CYP2C19  and  CYP3A4)  as  well
as UDP-glucuronyl  transferase  (UGT)  and  epoxide  hydro-
lases; on  the  contrary,  valproic  acid  is  the  most  important
inhibitor of  the  enzymes  (CYP2A6,  CYP2B6  and  CYP2C9)  in
drug metabolism.3,5
It  has  been  demonstrated  that  these  isoenzymes  are
involved in  the  metabolism  in  over  50%  of  anesthetic  agents.
Midazolam, one  of  the  most  widely  used  anesthetic  agents
with anticonvulsant  activity  in  MRI  procedures,  is  metabo-
lized by  CYP3A4/CYP3A5,  whereas  propofol  is  metabolized
by CYP2C9,  CYP2B6  and  UGTs.  Thus,  the  alterations  in  the
distribution and  clearance  resulting  from  the  simultaneous
use of  anesthetics  that  share  the  same  metabolic  pathways
with AEDs  will  change  the  duration  of  sedation  and  the  seda-
tion level  needed.6--8
G
t
dIn  the  present  study,  we  aimed  to  investigate  whether
here was  a  difference  in  terms  of  the  adequate  duration  of
edation, the  additional  sedative  agent  used  or  needed  to
escue sedative  agents  among  epileptic  children  using  AEDs
hat cause  either  enzyme  induction  or  inhibition,  or  those
hat did  not  use  AEDs  under  midazolam-propofol  anesthesia
uring MRI.
aterials and methods
his  study  was  approved  by  the  Ethics  Committee  of
he Institutional  Human  Research  Board  of  Mustafa  Kemal
niversity. Overall,  120  children  with  epilepsy  (American
ociety of  Anesthesiology  (ASA)  I,  II;  aged  3--10  years)
ndergoing cranial  MRI  with  sedation  were  included  in  this
rospective clinical  trial.
Epileptic  children  were  classiﬁed  into  three  groups  as
ollows: Group  1,  children  using  agents  that  cause  CYP-450
nduction (n  =  30);  Group  2,  children  using  agents  that  cause
YP-450 inhibition  (n  =  30);  and  Group  3,  those  not  receiving
EDs (n  =  60).
The  day  before  the  MRI,  all  patients  were  assessed
y an  anesthesiologist,  including  history  of  current  dis-
ase, medical  history  and  physical  examination.  All  parents
ere informed  of  the  fasting  periods  allowed  under  the
merican Society  of  Anesthesiologists  Preprocedure  Fasting
uidelines.9,10
The  children  with  a  risk  status  ≥ASA  III,  those  younger
han 3  years,  those  with  severe  pulmonary  or  cardiac  disor-
ers, congenital  head--neck  or  face  anomaly  and  excessive
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onsil  hypertrophy,  those  with  gastroesophageal  reﬂux  or  full
tomach, obese  children,  those  with  sleep-apnea,  and  those
ith abnormal  renal  function  tests  or  a  history  of  allergy
gainst agents  used  in  the  study  or  a  history  of  difﬁculty
n previous  MRI  procedures  were  excluded.  Children  with
ccompanying diseases  such  as  cerebral  palsy  or  mental-
otor retardation  were  not  excluded  from  the  study.
Before  the  procedure,  written  informed  consent  was
btained from  parents.  Demographic  data  such  as  weight,
ge and  gender,  ASA  status,  history  of  epilepsy,  antiepileptic
edication and  accompanying  diseases  were  recorded.  In  all
atients, 0.5  mg  kg−1 midazolam  was  given  orally  by  mixing
t into  a  particle-free  fruit  juice  for  premedication  30  min
efore the  intravenous  catheter  placement,  and  patients
ere taken  into  the  MRI  room  when  the  Parental  Separation
nxiety Scale  reached  1--2.11,12 The  time  from  premedi-
ation with  oral  midazolam  to  arrival  in  the  MRI  room  was
eferred to  as  the  time  of  readiness  for  the  procedure  (seda-
ion ready).  In  both  groups,  0.05  mg  kg−1 midazolam  (i.v.)
as given  as  the  primary  sedative,  followed  by  1  mg  kg−1
ropofol  for  30  s.  The  sedation  level  was  assessed  through-
ut the  imaging  procedure  with  the  University  of  Michigan
edation Scale  (UMSS)13 and  it  was  considered  adequate
hen patients  could  be  awakened  only  by  signiﬁcant  physi-
al stimulus.  The  time  to  arrive  at  a  sufﬁcient  sedation  level
UMSS =  3)  was  referred  to  as  the  induction  time.  To  prevent
he pain  of  the  propofol  injection,  0.25  mg  mL−1 lidocaine
as added  to  the  same  syringe.14
When  sedation  and  immobilization  could  not  be  achieved
uring the  imaging  procedure,  a  midazolam  dose  was
itrated by  0.05  mg  kg−1 increments  (maximum  increment:
 mg  and  maximum  total  dose:  0.1  mg  kg−1),  and  a propofol
olus of  0.25--0.5  mg  kg−1 was  given  as  a  rescue  dose  when
idazolam titration  failed.  The  duration  between  the  ini-
ial dose  and  the  additional  sedation  needed  was  deﬁned  as
MSS <  3  and  movement  of  patient  causing  to  repeated  imag-
ng procedure.  Discomfort  or  inevitable  movement  of  the
hildren resulted  in  the  cancellation  of  the  imaging  despite
he fact  that  sedation  was  considered  as  inadequate  seda-
ion.
The heart  rate  and  peripheral  oxygen  saturation  were
onitored during  the  procedure  (MILLENNIA  3155MVS,  USA)
nd recorded  at  5-min  intervals.  Non-invasive  blood  pressure
easurements were  only  performed  before  and  at  the  end
f the  procedure  as  it  could  cause  awakening  due  to  muff.9
linically,  hypotension  was  deﬁned  as  a  20%  or  more  reduc-
ion in  systolic  artery  pressure  compared  with  the  baseline
alue.14
All  children  were  protected  from  noise  during  the  proce-
ure and  supplemented  with  2  mL  min−1 O2 via  a  face  mask
n order  to  maintain  spontaneous  respiration.  Intervention
ecisions were  made  in  cases  of  SpO2 <  94%,  apnea  lasting
0 s  (apnea),  a  decrease  in  the  heart  rate  by  more  than  20%
ompared to  the  baseline  value  (bradycardia)  and  arrhyth-
ias. Airway  support  maneuvers  were  performed  in  cases
f airway  obstruction  and  hypoxia,  including  tactile  stimu-
us, chin  lifting,  airway  placement  and  bag-mask  ventilation
fter the  discontinuation  of  the  MRI.14 In  addition,  adverse
vents occurring  during  induction,  MRI  and  before  discharge
ere recorded,  including  nausea,  vomiting,  apnea,  cough,
iccup, irritability,  agitation,  allergic  reaction  and  aspira-
ion.
b
i
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Data regarding  procedure  time,  termination  or  repetition
f the  MRI  procedure,  and  additional  midazolam  or  propofol
pplications were  recorded  for  all  patients.  The  duration  of
he procedure  was  deﬁned  as  the  time  from  the  initiation  of
he MRI  procedure  to  its  completion,  including  interruptions.
When  the  imaging  procedure  was  completed,  children
ere transferred  to  the  recovery  room  within  the  magnetic
esonance (MR)  unit  and  observed  by  parents  and  a  nurse
nesthesiologist. Recovery  time  was  deﬁned  as  the  time
rom completion  of  the  MRI  procedure  to  the  discharge  from
he recovery  room  (Modiﬁed  Aldrete  score  ≥  8  and  Comfort
cale score  ≥  3).14,15 The  children  were  then  transferred  to
he department  of  pediatrics  and  were  discharged  after  vital
igns and  levels  of  consciousness  returned  to  baseline  values.
Parents’  level  of  satisfaction  with  the  sedation  experi-
nce was  assessed  on  the  basis  of  a  4-point  Likert  scale  (very
issatisﬁed, somewhat  dissatisﬁed,  somewhat  satisﬁed  and
ery satisﬁed).  The  quality  of  MR  sequences  was  assessed
ccording to  the  presence/absence  of  artifacts  resulting
rom movement  of  the  patient  by  a radiologist  blinded  to
atients and  sedation  technique  via  a  3-point  scale:  (1)
xcellent, no  artifact  due  to  movement;  (2)  procedure  was
ompleted with  minor  movement;  and  (3)  major  movement
nd aborted  procedure.16
In  addition,  a  phone  interview  was  conducted  24  h  after
ischarge by  a  blinded  anesthesiology  resident  regarding
elayed adverse  events,  nocturnal  enuresis,  insomnia,  and
ightmares.
tatistical  analysis
PSS  for  Windows  version  13.0  (Statistical  Package  for  Social
ciences) was  used  for  all  statistical  analyses.  Sample  size
stimates were  based  on  the  duration  of  the  initial  dose  (in
inutes). It  was  estimated  that  a  sample  size  of  21  per  group
ould provide  80%  power  to  detect  a  clinically  meaningful
ifference of  1.5  min  when  the  accepted  standard  devia-
ion was  8.3  and  the  ˛  error  was  0.05.  Standard  deviation
as determined  based  on  a  pilot  study  on  epileptic  children
ndergoing MRI.
The  normal  distribution  of  continuous  variables  was
ested with  the  Kolmogorov--Smirnov  test.  Chi-square  tests
ere used  for  comparisons  between  categorical  variables.
ruskal--Wallis and  Mann--Whitney  U  tests  were  used  in
he comparisons  of  continuous  variables  between  groups.
 < 0.05  was  considered  signiﬁcant  for  all  statistical  data.
esults
he  data  were  obtained  from  120  epileptic  children,  using
ntiepileptic agents  for  focal  or  generalized  convulsions,
ho had  no  MRI  scan  and  received  sedation  for  MRI  that  was
erformed for  initial  diagnosis  or  for  evaluating  the  remis-
ion course  as  well  as  the  management  of  accompanying
iseases during  a  period  of  19  months  between  September,
012 and  April,  2013.
Table  1  presents  the  demographic  data  and  the  propor-
ion of  patients  with  the  rate  of  accompanying  diseases  in
oth groups.  Procedural  data  are  presented  in  Table  2.
The  mean  duration  of  epilepsy  was  signiﬁcantly  shorter
n Group  III  (30.78  ±  23.80)  compared  with  groups  I  and  II
58.83 ±  32.33  and  59.93  ±  33.85,  respectively;  p  =  0.001).
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Table  1  Patients  characteristic  data.
Group  I  (n  =  30)  Group  II  (n  =  30)  Group  III  (n  =  60)  p
Sex
Male  (%)  12  (40%)  14  (46.7%)  22  (36.7%)  0.659
Female  (%)  18  (60%)  16  (53.3%)  38  (36.3%)
Age  (month)  7.0  (3.0--10.0)  8.0  (3.0--10.0)  5.0  (3.0--10.0)a 0.003a
Weight  (kg)  22.0  (10.0--36.0)  22.5  (10.0--35.0)  16.0  (10.0--30.0)a 0.001a
ASA  I/II  17/13  14/16  27/33  0.567
Rate of  accompanying  (%)  11  (36.7%)  13  (43.3%)  25  (41.7%)  0.856
n, number of cases.
Results  are presented as median (min--max) except for gender, rate of accompanying and ASA physical status (count).
a p < 0.05.
Table  2  Procedural  data  in  three  groups.
Variable  Group  I  (n  =  30)  Group  II  (n  =  30)  Group  III  (n  =  60)
Sedation-ready  30.00  (30.00--35.00)  30.00  (20.00--35.00)  30.00  (20.00--40.00)
Induction  time 55.00  (50.00--60.00)  12.00  (10.00--15.00)  55.00  (45.00--60.00)
Duration  of  initial  dose  10.00  (5.00--13.00)a,b 12.00  (10.00--15.00)c 10.00  (8.00--15.00)
Additional  midazolam  dose 0.82 (0.00--1.80)a,b 0.00  (0.00--1.30)  0.00  (0.00--1.25)
Rescue  propofol  dose  0.00  (0.00--20.00)a,b 0.00  (0.00--12.00)  0.00  (0.00--12.50)
Duration  of  procedure  (min) 13.00 (7.00--25.00)a,b 10.00  (7.00--15.00)  10.00  (7.00--20.00)
Recovery  time  (min) 12.00  (10.00--18.00) 13.00  (10.00--30.00)  10.00  (7.00--20.00)
n, number of cases.
Statistically  signiﬁcant differences (p < 0.05) were noted as follows:
a Group I vs Group II.
b Group I vs Group III.
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The  duration  of  antiepileptic  medication  was  similar  in
groups I  and  II  (58.06  ±  32.00  mg,  59.60  ±  33.50,  respec-
tively; p  >  0.05).
The  duration  of  the  initial  dose  was  signiﬁcantly  shorter
in Group  I  when  compared  with  groups  II  and  III  (p  =  0.001  and
p =  0.003,  respectively).  It  was  signiﬁcantly  longer  in  Group
II when  compared  with  groups  I  and  III  (p  =  0.001  and  p  =  0.29,
respectively). The  initial  dose  protocol  with  midazolam  and
propofol was  adequate  to  complete  the  MRI  procedure  in  11
patients (36.7%)  in  Group  I;  in  21  patients  (70%)  in  Group
II; and  in  43  patients  (71.7%)  in  Group  III  (p  =  0.03).  For
the remaining  patients,  the  need  for  additional  midazolam
for adequate  sedation,  an  additional  midazolam  dose  was
increased in  Group  I  when  compared  with  groups  II  and  III
(p =  0.010,  p  = 0.001  and  p  =  0.003,  p  =  0.001,  respectively).
Also it  was  not  changed  in  Group  II  compared  with  Group  III.
In addition,  the  rescue  propofol  dose  was  signiﬁcantly  higher
only in  Group  I  when  compared  with  Group  III  (p  =  0.002).
No signiﬁcant  correlation  was  detected  between  the
duration of  the  antiepileptic  medication  and  the  duration  of
the initial  dose  or  the  dose  needed  for  additional  sedation
in groups  I  and  II.
The  duration  of  the  procedure  was  similar  in  groups  II
and III,  while  it  was  signiﬁcantly  higher  in  Group  I  when
compared with  groups  II  and  III  (p  =  0.034  and  p  =  0.004,
respectively).
Spontaneous respiration  was  achieved  without  the  need
for ventilation  support  in  all  patients.  Temporary  oxygen
A
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Mesaturation  (<95%)  was  observed  in  three  patients  in  Group
 (10%)  and  each  two  patients  (6.6%)  in  Group  II  and  Group
II immediately  after  the  initial  sedation  dose,  which  rapidly
esponded to  tactile  stimulus,  including  slight  neck  exten-
ion and  chin  support.
Although systolic  arterial  pressure  was  decreased  to
 level  of  10%  below  the  baseline  value  after  sedation,
ypotension was  not  observed  in  any  patient.  In  addition,
one of  the  patients  experienced  cardiovascular  adverse
vents, such  as  bradycardia  or  arrhythmia  during  or  after
edation. The  recovery  times  after  MRI  were  similar  among
he groups.
Paradoxical reaction,  early  or  delayed  adverse  effects
ere not  observed  in  any  patient  and  there  was  no  case
n which  the  MRI  procedure  could  not  be  completed  due  to
ailure of  sedation  or  a  major  movement,  and  no  patient
as excluded  from  the  study  on  these  grounds.  All  parents
ere very  satisﬁed  with  the  sedation  experience.  No  signiﬁ-
ant difference  was  observed  in  the  quality  of  MR  sequences
mong the  groups  (p  > 0.05).
iscussionlthough  unfavorable  effects  of  AEDs  on  CYP-450  enzyme
ystems are  well  known,  to  the  best  of  our  knowledge,  this  is
he ﬁrst  study  to  compare  the  interactions  of  anesthetics  in
RI. The  results  of  our  study  demonstrated  that  the  duration
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124  
f  the  initial  dose  of  midazolam-propofol  was  shorter  in  chil-
ren using  AEDs  that  cause  enzyme  induction,  while  it  was
rolonged in  children  using  AEDs  that  cause  enzyme  inhibi-
ion and  in  those  not  using  antiepileptic  agents.  Moreover,
he results  showed  that  additional  sedation  need  increased
n children  using  AEDs  that  cause  enzyme  induction,  while  it
ecreased in  cases  using  AEDs  that  cause  enzyme  inhibition.
We  suggested  that  the  variation  in  the  duration  of  ini-
ial doses  resulted  from  alterations  in  the  metabolism  of
nesthetic agents  caused  by  antiepileptic  agents  that  uses
ommon metabolic  pathways  with  midazolam  and  propofol.
As  such,  clinical  reﬂections  on  the  inducer  or  inhibitory
ffects of  AEDs  are  also  different  in  sedation  procedures.
he usage  of  AEDS  that  inhibit  enzyme  induction  can
horten the  sedation  period  of  sedatives,  thereby  resulting
n prolonged  procedural  times  due  to  frequent  repetitions.
onversely, AEDs  with  inhibitory  effects  may  prolong  seda-
ion as  well  as  the  recovery  time.  Both  situations  can  cause
issatisfaction in  children  and  their  parents,  resulting  in  a
aste of  time  and  money.2,14,17
In  our  study,  there  was  a  need  for  additional  doses;
hus, the  duration  of  the  procedure  was  markedly  increased
ecause of  signiﬁcantly  shortened  durations  under  the  initial
idazolam-propofol dose  in  children  using  AEDs  that  cause
nzyme induction.  In  a  study  on  epileptic  children  receiv-
ng phenobarbital  monotherapy,  Eker  et  al.2 reported  that
esults on  the  need  for  additional  sedation  and  the  dura-
ion of  sedation  were  in  agreement  with  our  study.  Similar
esults have  been  demonstrated  in  animal  models  regarding
nzyme induction.18,19
Although  the  duration  of  the  initial  doses  of  midazolam-
ropofol was  signiﬁcantly  prolonged  in  children  using  AEDs
hat cause  enzyme  inhibition,  this  did  not  result  in  problems
r adverse  effects.  Also,  it  did  not  result  in  a  prolonged  dura-
ion of  the  procedure  since  there  was  no  repetition  of  the
RI.
No correlation  was  detected  between  the  duration  of
he initial  midazolam--propofol  dose  and  the  need  for  addi-
ional doses  with  the  duration  of  the  medication,  including
nzyme inducing  or  inhibiting  agents.  The  induction  or  inhi-
ition caused  by  AEDs  was  concentration-dependent  and  was
ot related  to  the  duration  of  the  medication.20--23 Thus,  our
esults are  in  agreement  with  the  literature  in  this  area.
Although  the  demographic  characteristics  of  the  groups
ere largely  similar,  Group  III  consisted  of  younger  ages  and
ower mean  weights.  This  difference  was  attributed  to  the
ower mean  age  in  children  who  underwent  evaluations  for
ew diagnosis  in  Group  III.
While  metabolic  interactions  on  speciﬁc  CYP  isoenzymes
ay vary  depending  on  genetic  and  environmental  factors,
harmacokinetic and  pharmacodynamic  variations  can  also
e observed  in  relation  to  age.  CYP  and  UGT  isoenzymes  are
arkedly differentiated  during  the  maturation  of  children,
nd reach  adult  levels  at  2--3  years  of  age.21 We  think  that
ur results  were  not  affected  by  this  change  in  isoenzymes,
espite the  wide  age  range  in  our  study,  since  three  years
f age  was  selected  as  the  lower  limit  of  eligibility.
A  combination  of  phenobarbital  or  carbamazepine  with
nesthetic agents  with  a  similar  proﬁle  of  activity  may  also
nhance anesthetic  effects.1 In  our  study,  midazolam  and
ropofol were  preferred  because  of  the  shorter  time  of
ction and  their  association  with  comfortable  recovery.24 In
1I. Davarci  et  al.
ddition,  the  major  advantage  of  propofol  was  the  lack  of
aradoxical reactions.25 In  agreement  with  the  literature,  no
igniﬁcant adverse  effect  or  complication,  including  para-
oxical reactions  (sedation,  agitation,  and  irritability)  was
bserved in  our  patients.
In conclusion,  AEDs  have  many  physiological  and  phar-
acological effects  on  anesthetic  agents  and  are  the  most
mportant constituent  of  the  practice  of  anesthesia.  Anes-
hesiologists should  be  aware  of  important  drug  interactions
nd underlying  mechanisms  in  the  sedation  of  children  using
ntiepileptic  agents  and  required  dose  titrations  should  be
ade by  meticulously  observing  clinical  responses.
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